Spirax-Sarco Engineering PLC
14 May 2002
At the Annual General Meeting of Spirax-Sarco Engineering plc held at the Spirax
Sarco Training Centre, Cheltenham, Gloucester on Thursday, 9th May 2002 the
following resolutions considered as special business were passed:
1. That, subject to and in accordance with article 6 of the Company's articles of association, the
directors be authorised to allot relevant securities up to a maximum nominal amount of £6,100,000; that
this authority shall expire on 8th May 2007 and that all previous authorities under section 80 of the
Companies Act 1985 shall henceforth cease to have effect.
2. That, subject to and in accordance with article 7 of the Company's articles of association, the
directors be empowered to allot equity securities for cash provided that this power shall expire on the
8th May 2007 and shall be limited for the purposes of paragraph (1)(b) of article 7 to the allotment of
equity securities having a maximum nominal amount of £924,000 and that all previous authorities under
section 95 of the Companies Act 1985 shall cease to have effect.
3. That approval be and is hereby given to the exercise by the directors of the power conferred upon them
by article 109 of the Company's articles of association in respect of any dividends declared or paid in
respect of the financial years ending on 31st December 2006.
4. That in accordance with article 11 of its articles of association and the Companies Act 1985 the
Company is generally and unconditionally authorised to make market purchases (within the meaning of
Section 163 of the Companies Act 1985) of ordinary shares of 25p each in the capital of the Company ('
ordinary shares') on such terms and in such manner as the board of directors of the Company may from
time to time determine provided that:
(a) the maximum number of ordinary shares that may be purchased pursuant to this authority is 7,300,000;
(b) the maximum price which may be paid for an ordinary share purchased pursuant to this authority is an
amount equal to 105 per cent of the average of the middle market prices shown in the quotations for
the Company's ordinary shares in the London Stock Exchange Daily Official List for the five business
days immediately preceding the day on which that ordinary share is purchased and the minimum price
which may be paid is 25p per ordinary share (in each case exclusive of expenses payable by the
Company); and
(c) this authority will expire at the conclusion of the annual general meeting of the Company to be held in
2003 unless renewed before that time, but the Company may make a contract to purchase ordinary shares
under this authority before its expiry which will or may be executed wholly or partly after the expiry
of this authority, and may make a purchase of ordinary shares in pursuance of any such contract.
P A SMITH
Director & Company Secretary
Spirax-Sarco Engineering plc
Charlton House
Cheltenham
Glos.
GL53 8ER
Direct Tel. 01242 535355
Direct Fax: 01242 572515
petersmith@spiraxsarco.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.